BVI, a leading global provider of advanced surgical ophthalmology treatments, is proud to debut its newest and most cutting-edge facility in Liège, Belgium. The new … Read more

CEL-SCI Corporation, a Phase 3 cancer immunotherapy company, is excited to announce the pricing of a public offering of 2,500,000 shares of its common stock … Read more

On July 14, DONG-A ST, headed by CEO Min-Young Kim, celebrated a major milestone with confirmation of acceptance of their Marketing Authorization Application (MAA) for … Read more

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a developer of adult stem cell therapeutics for neurodegenerative diseases, has taken a bold step forward in its quest … Read more

Ligand Pharmaceuticals Inc. (NASDAQ: LGND) has made a remarkable offer to acquire the assets of Novan, Inc. (Nasdaq: NOVN). Their offer of a $15 million … Read more

Caeregen Therapeutics today announced that it has received $1.4 million from the NIH and NEI in the form of a Small Business Innovation Research (SBIR) … Read more

At the Alzheimer’s Association International Conference 2023 in Amsterdam, Cumulus Neuroscience (Cumulus; The Company) unveiled interim findings from their real-world feasibility study CNS-101 which demonstrated … Read more

Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (Nasdaq: CYTO) has exciting news for those living with house dust mite (HDM) allergic rhinitis: the detailed results … Read more

CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leading player in the field of conditionally activated, localized biologics, has announced the appointment of Yu-Waye (Wayne) Chu, M.D. … Read more

Lyndra Therapeutics has announced a major leadership shakeup, with long-time Lyndra executive Jessica Ballinger becoming President and CEO, Chief Medical Officer Richard Scranton, M.D., M.P.H. … Read more

Beckman Coulter Diagnostics and Fujirebio Inc., two world-renowned leaders in clinical diagnostics and neurological markers respectively, have joined forces to revolutionize therapeutic development and clinical … Read more

Tivic Health® Systems, Inc., a leading health tech company, has today announced the pricing of its highly anticipated public offering of 51,250,000 common shares. At … Read more

Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company that develops groundbreaking cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases, … Read more

Ardelyx Inc. (Nasdaq: ARDX), a biopharmaceutical company on a mission to revolutionize modern medicine, today announced that its New Drug Application (NDA) for tenapanor has … Read more

Akari Therapeutics, Plc (Nasdaq: AKTX) has made exciting progress in its development of nomacopan, an advanced therapy for treating hematopoietic stem cell transplant-related thrombotic microangiopathy … Read more

LabCorp (NYSE: LH), a leading global life sciences company, is excited to share that its Board of Directors has declared a cash dividend of $0.72 … Read more

Nymox Pharmaceutical Corporation (OTC Markets – NYMXF) is pleased to share updates in regard to their Board of Directors and management. Furthermore, they would like … Read more

Imaging Biometrics, LLC, a wholly-owned subsidiary of IQ-AI Ltd, is proud to announce that the US Food and Drug Administration (US FDA) has granted it … Read more

Rarebase, the innovative biotechnology company that is revolutionizing drug discovery and development at record speed, scale, and capital efficiency, is excited to announce that Chris … Read more

Sagimet Biosciences Inc. (Nasdaq: SGMT), an emerging clinical-stage biopharmaceutical company with a mission to develop novel therapeutics that target dysfunctional metabolic pathways, is pleased to … Read more

RayCare 2023B has taken the radiotherapy treatment course management to the next level with an integrated and seamless workflow process. From prescription to results review, … Read more

InnoCare Pharma and ArriVent Biopharma are joining forces to explore the potential benefits of combining InnoCare’s SHP2 allosteric inhibitor, ICP-189, and ArriVent’s furmonertinib, an EGFR … Read more

George Medicines has made a dramatic breakthrough in combatting cardiometabolic disease. After successfully enrolling all their patients in the Phase III, active-controlled trial, the Company … Read more

Eitan Medical is revolutionizing the world of infusion therapy and drug delivery solutions with the launch of their new cloud-based Eitan Insights system. Proactively putting … Read more

ExoCoBio, the forefront of exosome-based regenerative aesthetics, is proud to announce that they have taken a majority stake in BENEV, one of the world’s most … Read more

Dr. Reddy’s, a renowned global pharmaceutical firm has recently made a quantum leap forward in advancing its proposed biosimilar rituximab candidate DRL_RI, with the U.S. … Read more

Wavely Diagnostics, Inc., a pioneering digital diagnostics company, just secured $1.35MM in new funding to boost its groundbreaking platform for data-driven virtual pediatric care. Serving … Read more

Current Surgical Inc., a medical technology company working to revolutionize the safety and efficacy of cancer surgery, has been awarded a remarkable $400,000 grant from … Read more

Nymox Pharmaceutical Corporation [OTC Markets – NYMXF] is delighted to share the news that they have welcomed Patrick Doody aboard as their new Vice President, … Read more

Pluri Inc.(Nasdaq: PLUR) (TASE: PLUR) today announced the much-anticipated appointment of Lorne Abony to its Board of Directors. The innovative biotech giant seeks to use … Read more

Opthea Limited (NASDAQ:OPT; ASX:OPT) is excited to announce that their groundbreaking VEGF-C/D “trap” inhibitor, OPT-302, will be featured at the upcoming 2023 American Society of … Read more

SoftWave Tissue Regeneration Technologies is celebrating a major game-changing moment for men’s sexual health treatments: the approval of the CPT Editorial Panel’s reimbursement code X170T … Read more

West Pharmaceutical Services, Inc. (NYSE: WST) is set to release its second-quarter 2023 financial results next week on Thursday, July 27. The global leader in … Read more

Today, Halozyme Therapeutics, Inc., announced incredible news: The OCARINA II trial, evaluating Roche’s OCREVUS® (ocrelizumab) with Halozyme’s ENHANZE® as a twice-yearly, 10-minute subcutaneous injection, successfully … Read more

HUTCHMED (China) Limited—the company whose shares are traded on Nasdaq/AIM (HCM) and Hong Kong Exchange (13)—is pleased to announce that after July 13, 2023, it … Read more

Bicycle Therapeutics plc, a biotechnology company that has developed a differentiated class of therapeutics utilizing its groundbreaking Bicycle® technology, announced the pricing of an underwritten … Read more

ObsEva SA (SIX: OBSN) is thrilled to announce that it has regained full exclusive global rights to nolasiban, a revolutionary oral oxytocin receptor antagonist that … Read more

Biopharma giant BioGeneration Ventures (BGV) has raised its biggest fund yet, closing its fifth fund at an impressive €150 million. BGV has established itself as … Read more

EG 427, a pioneering biotechnology company leading the revolution to develop revolutionary pinpoint DNA medicine solutions, today announced that its Series A financing round has … Read more

Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR) is pleased to announce that the preliminary (unaudited) financial results for its second quarter and first half of … Read more

Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ Stockholm:CALTX) today showcased impressive interim data from the Phase 2 trial of its lead product candidate, setanaxib, in patients … Read more

The groundbreaking work of researchers from The London Psychiatry Centre (TLPC) could revolutionise the treatment of bipolar spectrum disorder, as they have identified genetic biomarkers … Read more

Fresenius Kabi is proud to announce the immediate launch of Ganirelix Acetate Injection, its generic injectable fertility drug. With this introduction to the women’s health … Read more

Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) is pleased to welcome Christopher Bull to its Board of Directors! Mr. Bull is joining the team … Read more

LabCorp (NYSE: LH), a global leader in the delivery of innovative and comprehensive laboratory services, is pleased to announce that it has acquired select assets … Read more

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical committed to developing innovative, life-saving treatments for cancer patients, is pleased to announce that Dan Paterson will assume the … Read more

Ginkgo Bioworks and Novo Nordisk have achieved a major milestone in their recently announced partnership, successfully completing the pilot phase of their collaboration. Working together, … Read more

Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company that has developed two commercially available oral immunotherapeutic products for the treatment of gut mediated … Read more

Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company striving to provide groundbreaking treatments to patients with urgent medical needs, is proud to announce that … Read more

Today, the March of Dimes National Board of Trustees announced the appointment of Dr. Elizabeth Cherot as its new President and Chief Executive Officer, effective … Read more

Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) announced today that Bristol Myers Squibb Company (NYSE:BMY) has chosen to enter into an exclusive … Read more

Metabion has upped its production capacity for therapeutic and diagnostic oligonucleotides and their derivatives. Over the last couple of years, the company has developed a … Read more

AlzeCure Pharma AB (publ)(FN STO:ALZCUR), a pharmaceutical company dedicated to developing small molecule candidate drugs for diseases affecting the central nervous system, has released a … Read more

The Company, Sosei Group Corporation (TSE: 4565), is set to release its financial and operational accomplishments for the 6 months ended 30 June 2023 on … Read more

Hummingbird Diagnostics GmbH, a pioneering name in the field of blood-based small RNAs for early disease detection and characterization, has announced an exciting publication in … Read more

Doer Bio, a clinical stage biopharmaceutical company, has partnered with BioNTech SE to develop innovative biotherapeutics for metabolic diseases and cancers. This exciting new agreement … Read more

Astellas Pharma Inc. and 4D Molecular Therapeutics, Inc. have reached an exciting new agreement – Astellas has been granted access to the intravitreal retinotropic R100* … Read more

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) is pleased to announce that, to reward ten new employees for joining the team, the Board of Directors’ Compensation Committee … Read more

Iovance Biotherapeutics, Inc. (Nasdaq: IOVA) announced the pricing of its initial public offering of 20,000,000 shares of common stock at $7.50 per share, for projected … Read more

Pixium Vision SA, a bioelectronics company that develops innovative bionic vision systems to help visually impaired individuals gain independence, has negotiated a successful extension of … Read more

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) announced exciting news today: the first patient has been dosed in a clinical trial sponsored by Sanofi, … Read more

The Company today announced the completion of its sale and investment solicitation process (SISP) with First Generation Capital Inc., who was selected as the successful … Read more

Exciting News: Curis, Inc. (Nasdaq: CRIS), a cutting-edge biotechnology company, is making waves in the world of hematologic malignancy treatments! Today, they announced a game-changing … Read more

Exciting News: T2 Biosystems, Inc. (NASDAQ:TTOO), a cutting-edge company known for its lightning-fast detection of sepsis-causing pathogens and antibiotic resistance genes, has just made a … Read more

Get ready to be amazed by the groundbreaking innovation from Stryker! Introducing the Ortho Q Guidance system, a game-changer in the medical industry. This revolutionary … Read more

Get ready for some exciting news from VBI Vaccines Inc. (NASDAQ: VBIV)! This innovative biopharmaceutical company is all about harnessing the power of immunology to … Read more

Get ready for an exhilarating event! Mustang Bio, Inc., a cutting-edge biopharmaceutical company, is igniting the medical world with its groundbreaking cell and gene therapies. … Read more

Exciting News from Inovedis GmbH: FDA Clearance Received for Revolutionary Implant System to Fix Shoulder Tear! Inovedis GmbH, an innovative medical technology start-up, is making … Read more

Introducing CoImmune, Inc., an innovative company on the forefront of immuno-oncology research. They are revolutionizing cancer treatment by harnessing the power of cellular immunotherapies. Today, … Read more

Exciting News: Celldex Therapeutics, an innovative biotech company (NASDAQ:CLDX), has just kicked off a groundbreaking Phase 2 study that could potentially revolutionize the treatment of … Read more

Today, Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) made a groundbreaking announcement that is set to change the lives of pediatric and young adult patients with OI … Read more

Introducing TellBio, Inc., the visionary biotechnology company that’s disrupting cancer detection as we know it! With their groundbreaking TellDx System, which harnesses the power of … Read more

Cassava Sciences Inc. (Nasdaq: SAVA) made an exciting and groundbreaking announcement today with the release of top-line clinical results from its Cognition Maintenance Study (CMS). … Read more

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) welcomed seven new employees, granting each an exciting package of incentives to join the team. An aggregate of 60,250 restricted … Read more

On June 30, 2023, Cytokinesis, Inc. (Nasdaq: CYTK) granted 77,450 stock options to five new hires as an incentive to join their team. The options … Read more

Sequana Medical NV (Euronext Brussels: SEQUA) is proud to announce a major milestone in the medical field – the successful implantation of its 1,000th alfapump … Read more

Gerresheimer has achieved impressive results for the first half of the year with organic revenue growth of 16.6%. The company has benefited from the increasing … Read more

We invite you to join us on July 20th, 2023 to learn more about the success of Hansa Biopharma AB (Nasdaq Stockholm: HNSA) as we … Read more

Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) is all set to share its Second Quarter 2023 financial results with the world! On Wednesday, July … Read more

Brii Biosciences (2137.HK) has significantly expanded its commitment to combatting Hepatitis B Virus (HBV) infection through new license agreements with VBI Vaccines, Inc. (NASDAQ: VBIV). … Read more

The groundbreaking findings of a research study published in Nature Medicine show that single-cell genomic technologies developed by 10x Genomics can explain why some children … Read more

Today, Ascentage Pharma (6855.HK) achieved a major milestone by receiving approval from the Center for Drug Evaluation (CDE) of the China National Medical Products Administration … Read more

TiumBio Co., Ltd. (KOSDAQ: 321550) and Hansoh Pharmaceutical Group Co., Ltd. (SEHX: 3692) are thrilled to announce that the China National Medical Products Administration (NMPA) … Read more

I-Mab, a biopharmaceutical company dedicated to discovering, developing, and commercializing innovative immunotherapies, has achieved a major milestone with the publication of a manuscript entitled “CLDN18.2 … Read more

Coya Therapeutics, Inc. (NASDAQ: COYA), a clinical-stage biotechnology company, is proud to announce the appointment of Dr. Fred Grossman as President and Chief Medical Officer. … Read more

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the groundbreaking leader in precision genetic medicine for rare diseases, has successfully sold its Rare Pediatric Disease Priority Review Voucher (PRV) … Read more

Genprex is thrilled to announce that the China National Intellectual Property Administration has granted Patent No. 201780076886.X, protecting their lead drug candidate, REQORSA Immunogene Therapy, … Read more

The Preeclampsia Foundation invites investigators meeting the program’s criteria to submit Letters of Intent for the Peter Joseph Pappas Research Grants funding program to accelerate … Read more

A unique neuroimaging biomarker has been identified for major depressive disorder (MDD), one of the most disabling and wide-spread mental health conditions, by researchers at … Read more

EDP Biotech Corp. and New Day Diagnostics, LLC are excited to announce their partnership, uniting to create a single entity that will revolutionize the development … Read more

Visiox Pharmaceuticals, Inc., a privately-funded biopharmaceutical company dedicated to developing and commercializing ophthalmic drugs to address prevalent diseases in need of new treatment options, is … Read more

Altamira Therapeutics Ltd., publicly traded on Nasdaq as CYTO, is proud to announce its collaboration and option agreement with Italy-based Heqet Therapeutics s.r.l. Heqet has … Read more

Palisade Bio, Inc. (Nasdaq: PALI), a biopharmaceutical company striving to develop treatments for acute and chronic GI complications, has achieved a key milestone by completing … Read more

Doug Rice has been appointed as MiMedx Group, Inc.’s (Nasdaq: MDXG) Chief Financial Officer, effective today. He joins the Company following his nearly decade-long tenure … Read more

Sorrento Therapeutics, Inc. is pleased to announce the exciting results of the China phase IIa study of Abivertinib in the treatment of Patients with Relapsed/Refractor … Read more

PENTAX Medical is delighted to announce the appointment of David Harrison as President of the Americas, beginning July 1, 2023. With this new leadership, PENTAX … Read more

Propanc Biopharma, Inc. (OTC Pink: PPCB), a biopharmaceutical company developing novel cancer treatments, is pleased to announce that synthetic recombinant proenzymes trypsinogen and chymotrypsinogen were … Read more

The Kleine-Levin Syndrome Foundation proudly unveils the new and improved diagnostic criteria for Kleine-Levin Syndrome (KLS), as featured in the much-anticipated International Classification of Sleep … Read more

Evolution Optiks Limited is thrilled to announce that Prof. Dr. Thomas Neuhann has joined their ranks of prestigious Advisory Board members. With over four decades … Read more

Liberate Medical, an innovator in the world of transformative respiratory care, has achieved success with the recent closure of its $6.2 million Series B financing … Read more

Abbot’s AVEIR™ dual chamber (DR) leadless pacemaker system has been given the green light by the U.S. Food and Drug Administration and it’s the world’s … Read more

Ayala Pharmaceuticals, Inc. (OTCQX: ADXS) is pleased to announce that it recently concluded a successful End-of-Phase-2 (EOP2) meeting with the U.S. Food and Drug Administration … Read more

Akari Therapeutics, Plc (Nasdaq: AKTX) is proud to announce the appointment of industry veteran Wa’el Hashad to its Board of Directors as an independent director. … Read more

Daxor Corporation (NASDAQ: DXR) proudly announces that the United States Defense Health Agency (DHA) has awarded the Company a $1.1 million contract for Phase II … Read more

Agile Therapeutics Inc. (NASDAQ:AGRX) has been given a buy rating and $12 price target by investment firm H.C. Wainwright & Co, and although the women’s … Read more

ORYZON Genomics, S.A., a clinical-stage biopharmaceutical company using epigenetics to develop effective therapies for diseases with a major unmet medical need, today released preliminary aggregate … Read more

Talis Biomedical Corporation (Nasdaq: TLIS) announced today that it will be effecting a 1-for-15 reverse stock split of its issued and outstanding common stock, effective … Read more

Biora Therapeutics, Inc. (Nasdaq: BIOR) has taken a major step forwards in its transformation, successfully concluding an agreement with a major diagnostics company for the … Read more

F-star Therapeutics, an invoX company, announced today an exciting strategic discovery collaboration and licence agreement with Takeda. Leveraging F-star’s proprietary fully-human Fcab™ and tetravalent mAb²™ … Read more

InnoCare Pharma (HKEX: 09969; SSE: 688428), a top biopharmaceutical company involved in the development of treatments for cancer and autoimmune diseases, has successfully dosed its … Read more

Microba Life Sciences Limited (ASX: MAP) is thrilled to announce they have locked in a commercial agreement with leading pathology provider Sonic Healthcare Limited (ASX: … Read more

Ken Paulus is stepping down from his position as President and CEO of Prime Therapeutics LLC, a pharmacy benefit manager (PBM) serving nearly 38 million … Read more

Evelo Biosciences, Inc. (Nasdaq: EVLO), a clinical-stage biotechnology company developing an innovative platform of oral inflammation-combating medicines that target the small intestinal axis (SINTAX), today … Read more

Microbot Medical Inc. (Nasdaq: MBOT) is proud to announce the successful completion of an extended pre-clinical study with leading key opinion leaders (“KOLs”) at a … Read more

Vir Biotechnology, Inc. (Nasdaq: VIR) is pleased to welcome Sasha Damouni Ellis a vital addition to the Executive Management Team as the company’s new Executive … Read more

The field of neurosurgery has come a long way in its hundred year journey. From the inception of brain anatomy to the digitised medical imaging … Read more

GBP410 (also known as SP0202), SK bioscience’s innovative 21-valent pneumococcal conjugate vaccine candidate, has yielded remarkable results in its Phase II clinical trials with infants. … Read more

Intensity Therapeutics, Inc. is thrilled to announce the successful upsized initial public offering of its 3,900,000 shares of common stock at a remarkable $5.00/share. In … Read more

The U.S. Food and Drug Administration (FDA) has just approved AAV5 DetectCDx™, an innovative companion diagnostic developed by SARUP Laboratories that will help in identifying … Read more

Spexis AG (SIX: SPEX) has enlisted Maxim Group LLC, a full-service investment banking firm headquartered in New York, to evaluate potential strategic alternatives and fundraising … Read more

Bioheart and its holding subsidiary Angiocare are proud to announce the incredible clinical results of Iberis-HTN at the China Interventional Therapeutics 2023 conference. Led by … Read more

Poxel SA (Euronext: POXEL – FR0012432516), a clinical stage biopharmaceutical company dedicated to developing treatments to battle chronic serious diseases involving metabolic pathophysiology, such as … Read more

Researchers from the AMRA and Linköping University have joined forces to examine how personalized imaging-derived obesity phenotypes can be used to determine an individual’s cardiometabolic … Read more

Recently, Sanyou Biopharmaceuticals Co., Ltd. and Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd., a subsidiary of Huadong Medicine Co., Ltd., have forged a powerful collaboration through … Read more

Pacific Bio, the renowned developer of accurate sequencing solutions, recently announced that Bioscientia is utilising its Revio Long-read Sequencing Systems to extend genomics research projects, … Read more

Synlogic Inc., a clinical-stage biotechnology company striving to make a difference in the lives of those living with serious diseases, is pleased to announce that … Read more

Dr. Joseph M. Forbess, a renowned pediatric cardiovascular surgeon, has joined Nicklaus Children’s Pediatric Specialists (NCPS) as its Chief of the Section of Cardiovascular Surgery, … Read more

Astellas Pharma Inc. and Mitsui Fudosan Co. Ltd. have joined forces to create a revolutionary innovation hub, “TME imaging and interactive research for innovation (TME … Read more

At its 2023 annual general meeting of shareholders held on June 28, 2023, Rakovina Therapeutics Inc. (TSXV: RKV) was pleased to announce the re-election of … Read more

CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company devoted to developing cutting-edge treatments to battle dangerous diseases and conditions, recently announced the pricing of an underwritten … Read more

Today Sanofi is proud to introduce its Vaccines Investor Event, featuring key members of its leadership team discussing their exciting breakthroughs in the vaccines pipeline. … Read more

Today, the U.S. Food and Drug Administration’s Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) has taken a huge step forward in the path towards providing … Read more

Predictive Oncology Inc. (NASDAQ: POAI) is thrilled to welcome biopharmaceutical finance veteran Mr. Andrew Einhorn to its Business Advisory Board. With an extensive background in … Read more

Immutep (formerly known as Prima Biomed) Limited (ASX: IMM; NASDAQ: IMMP) today announced the successful completion of its A$80 million capital raise, providing the company … Read more

OmicsEdge is proud to present its remarkable new genotype imputation method at the European Society of Human Genetics (ESHG) meeting in Glasgow. This innovative method … Read more

At its Annual General Meeting of Shareholders held on Monday, June 26, 2023 in Madrid, Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY) received an overwhelming … Read more

Microba Life Sciences Limited (ASX: MAP) is excited to announce the successful dosing of the first participants in their Phase I Clinical Trial of MAP … Read more

Sihuan Pharmaceutical Holdings Group Ltd. and its subsidiaries are delighted to announce that Xuanzhu Biopharmaceutical Co., Ltd. – a non-wholly owned subsidiary of the company … Read more

Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) is delighted to announce that preliminary analysis of data from the phase IIa clinical study SPAGOPIX-02 demonstrates that SN132D has a promising … Read more

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura) has announced positive results from the Phase 3b DAYLIGHT trial for fezolinetant, an investigational oral, … Read more

On June 23rd, Kalos Medical Inc., a developer of revolutionary medical devices used to treat hypertension and other chronic illnesses, was awarded the Innovative Medical … Read more

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is offering a unique opportunity to invest in a biopharmaceutical company developing cutting-edge therapies for central nervous system (CNS) disorders. … Read more

Clene Inc. (Nasdaq: CLNN), along with its subsidiary Clene Nanomedicine, is leading the revolution in the treatment of neurodegenerative diseases. Recently, their efforts have been … Read more

Medtronic is delighted to welcome Greg Lewis from Honeywell onto its Board of Directors. Arriving on June 26th, Lewis will bring expansive expertise and insight … Read more

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Lonza (SIX: LONN) announced an exciting collaboration that will make strides in improving the lives of individuals with T1D. … Read more

BioAtla, Inc. (Nasdaq: BCAB) has been added to the U.S. small-cap Russell 2000® Index, effective after the U.S. markets open on June 26, 2023. As … Read more

Sutro Biopharma and Blackstone are proud to announce a revolutionary collaboration: Blackstone Life Sciences will provide Sutro with a $140 million upfront and up to … Read more

AVITA Medical, Inc., a leading regenerative medicine company focused on developing groundbreaking devices and autologous cellular therapies for skin restoration, is proud to announce that … Read more

Verona Pharma plc (Nasdaq: VRNA) is proud to announce their submission of a New Drug Application (NDA) to the US Food and Drug Administration (FDA) … Read more

Today marks a major development as the Phase 2b study of amlitelimab, known as STREAM-AD, has yielded promising results in adults suffering from moderate to … Read more

On June 20, 2023, Coherus BioSciences, Inc. (Nasdaq: CHRS) announced an exciting new employee incentive plan. The Company’s Board of Directors’ Compensation Committee had granted … Read more

Kinarus Therapeutics Holding AG (“Kinarus”) (SIX: KNRS) is thrilled to announce the signing of subordinated bridge loan agreements with existing shareholders, bolstering its liquidity while … Read more

Portage Biotech Inc. (NASDAQ: PRTG) is making waves after dosing the first patient in its Phase 1a trial, ADPORT-601 (NCT04969315). This trial is investigating a … Read more

Sorrento Therapeutics, Inc. (OTC: SRNEQ) has made a major breakthrough in the battle against the novel coronavirus (COVID-19). The company has successfully completed the full … Read more

Benitec Biopharma Inc. (NASDAQ: BNTC), a clinical-stage, gene therapy-focused biotechnology trailblazer, is proud to announce that the U.S. Food and Drug Administration has cleared its … Read more

Agile Therapeutics is making a move to bring Twirla to even more people. Starting in July 2023, the women’s healthcare company is partnering with MMCAP … Read more

Medtronic has appointed Greg Lewis, the Senior Vice President and Chief Financial Officer at Honeywell, to its Board of Directors! With effect from June 26, … Read more

Marker Therapeutics, Inc. has announced exciting new non-clinical data on its lead multi-tumor-associated antigen (multiTAA)-specific T cell product candidate, MT-401. After treatment with hypomethylating agents … Read more

Larkspur Biosciences made a groundbreaking announcement today – they have discovered a revolutionary new therapeutic target called TIM-1. This fundamental discovery of the vital B-cell … Read more

Avalo Therapeutics Inc. (Nasdaq: AVTX) has just released topline results from its clinical trial examining AVTX-002 (anti-LIGHT mAb) in patients suffering from difficult-to-manage non-eosinophilic asthma. … Read more

FibroGen, Inc. (NASDAQ: FGEN) has just announced the topline results from their Phase 3 ZEPHYRUS-1 trial evaluating the safety and efficacy of pamrevlumab on patients … Read more

Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy innovator, has just raised $34 million before placement agent and transaction fees in the second closing of … Read more

XOMA Corporation has acquired the royalty and milestone rights associated with two cutting-edge assets from LadRx Corporation. Arimoclomol, an oral therapeutic for Niemann-Pick disease type … Read more

Microbot Medical Inc. (Nasdaq: MBOT), the innovative developer of the LIBERTY® Robotic Surgical System, is proud to announce an expansion of its global IP portfolio … Read more

TransCode Therapeutics, Inc. (NASDAQ: RNAZ) has made a game-changing breakthrough in their quest to more effectively treat cancer! Their lead therapeutic candidate, TTX-MC138, has had … Read more

NurExone Biologic Inc. is delighted to share an incredibly positive preclinical study result related to its investigational drug ExoPTEN. Imaging results confirmed successful regeneration of … Read more

Relief Therapeutics, a biopharmaceutical company dedicated to providing innovative therapeutic solutions that offer transformative benefits to patients affected by select rare and special diseases, is … Read more

Relief Therapeutics’ subsidiary APR Applied Pharma Research SA and Vector Pharma FZCO of the World Orphan Drug Alliance (WODA Alliance) have struck a long-term distribution … Read more

Today, restor3d, Inc. and Conformis, Inc. (NASDAQ: CFMS) have entered into a game-changing merger agreement; restor3d, a revolutionary 3D printed orthopedic company, will be acquiring … Read more

SK pharmteco is making strides in the global market with the successful completion of its second Cell and Gene Therapies (C&GT) manufacturing facility in Europe. … Read more

RevolKa Ltd., a venture-backed biotech company utilizing its game-changing protein engineering technology platform (Shiro Kataoka, CEO), has achieved a milestone by successfully completing the collaborative … Read more

IGM Biosciences, Inc. (NASDAQ: IGMS) has just launched an upsized underwritten public offering of 3,285,327 shares of voting common stock and 7,312,500 shares of non-voting … Read more

Jacques Mascaro has been appointed the new Chair of the Board of Directors of Accumulus Synergy, a nonprofit trade association striving to accelerate digital transformation … Read more

Nuo Therapeutics is thrilled to announce that the Aurix® System has been added to the formulary of Wound Care Advantage (WCA), the leading wound care … Read more

Spaulding Clinical is revolutionizing clinical research by adding ADME (Absorption, Distribution, Metabolism, and Excretion) trial services to its industry-leading lineup of CRO services. By expanding … Read more

Propanc Biopharma, Inc., a biopharmaceutical company focused on developing innovative treatments for patients suffering from recurrent and metastatic cancers, is excited to announce a shareholders … Read more

Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) has announced the commencement of a groundbreaking triple immunotherapy combination study with the dosing of the first patient. This … Read more

Ginkgo Bioworks, a leader in cell programming and biosecurity technology, recently released their 2022 Sustainability Report ‘Caring at Ginkgo’. Through this, they shed light on … Read more

PolyPid Ltd. (Nasdaq: PYPD), a late-stage biopharma company, has announced that the first patient has been recruited for its revised SHIELD II Phase 3 trial, … Read more

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the groundbreaking RNA oncology company, has released highly anticipated findings concerning its lead therapeutic candidate, TTX-MC138, in a supplemental issue … Read more

Parthenon Therapeutics, a precision oncology company on a mission to revolutionize the tumor microenvironment (TME), has made a remarkable breakthrough in research collaboration with the … Read more

NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) has just announced a major coup – a securities purchase agreement with a single health-care focused institutional investor. The agreement … Read more

Enveda Biosciences, a biotechnology company unlocking vital medicines from natural sources, has released details of its powerful AI model MS2Mol. Through its ability to accurately … Read more

Molecular Targeting Technologies, Inc. (MTTI) has recently released encouraging data from a followed-up study of the efficacy of EBTATE (2 cycles, 3.7 GBq/cycle) for the … Read more

Ferrer, an international pharmaceutical company, is extending its phase III clinical trial ADORE (ALS trial with Daily ORal Edaravone) with FNP-122 for amyotrophic lateral sclerosis … Read more

UNION therapeutics A/S (UNION), a clinical stage pharmaceutical development company, is excited to announce a major breakthrough in the treatment of HS; an inflammation-driven, scarring … Read more

At the European Association for the Study of the Liver (EASL)’s The International Liver Congress™ 2023, CymaBay Therapeutics, Inc. (NASDAQ: CBAY) presented new findings from … Read more

Interius BioTherapeutics, a leader in in vivo cell-specific genetic medicine, revealed groundbreaking preclinical data at the Cellicon Valley 2023 Meeting in Philadelphia. Showcasing the power … Read more

Jadeite Medicines Inc., a Tokyo-based clinical-stage biopharmaceutical company, led by President and CEO Eiichi Takahashi, has been granted Orphan Drug Designation for odevixibat from the … Read more

BioInvent International AB (Nasdaq Stockholm: BINV) is proud to announce the promising results of their Phase 1/2a trial of their revolutionary anti-TNFR2 antibody BI-1808 as … Read more

Arbutus Biopharma’s on-going clinical trial results have been unveiled at the EASL Congress today, showcasing the safety, tolerability and antiviral efficacy of combining AB-729, their … Read more

Delix Therapeutics, a clinical-stage neuroscience company dedicated to discovering breakthrough treatments for psychiatric and neurological conditions, is delighted to announce a major milestone with the … Read more

At the 29th Congress of European Rhinologic Society (ERS2023), Longbio Pharma (Suzhou) Co., Ltd. announced that its preliminary phase I data of LP-003, a new … Read more

ADvantage Therapeutics, Inc. continues its pioneering approach in treating Alzheimer’s disease as authorities in Poland, Bulgaria, and Slovakia recently gave the green light to an … Read more

Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) is pleased to announce that its AR-301 clinical program has been recognized as a potential candidate for the U.S. Food … Read more

HAYA Therapeutics, SA, a biotechnology innovator developing groundbreaking RNA-guided programmable precision medicines centered around long non-coding RNAs, is pleased to announce the appointment of Douglas … Read more

Zynex, Inc., a groundbreaking medical technology company, has just received 510(k) market clearance from the FDA for the CM-1600 blood and fluid volume monitoring device! … Read more

PixCell Medical, the premier provider of fast, reliable hematology testing solutions for point-of-care use, is thrilled to announce the appointment of Guy Frak as Chief … Read more

Akebia Therapeutics, Inc. (Nasdaq: AKBA) has just made a remarkable announcement: Vafseo® (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor, has been granted marketing … Read more

Regulus Therapeutics is on the brink of a medical breakthrough – unlocking the potential of inhibiting miR-155 to treat Amyotrophic Lateral Sclerosis (ALS), also known … Read more

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a renowned developer of innovative adult stem cell treatments for neurodegenerative diseases, has appointed Nir Naor, CPA, CFA, MBA … Read more

Sling Therapeutics, Inc., a biopharmaceutical company dedicated to finding effective treatments for thyroid eye disease (TED), is proud to announce data from a recent presentation … Read more

Ascendis Pharma A/S (Nasdaq: ASND) has just released their one-year data from the PaTHway Trial of their TransCon PTH treatment for hypoparathyroidism. The results, presented … Read more

Seres Therapeutics, Inc. (Nasdaq: MCRB) and Nestlé Health Science are proud to announce findings from a Phase 3 Development Program analysis for VOWST™ (fecal microbiota … Read more

Sensorion, a leading biotechnology innovator in hearing loss therapies, is thrilled to present promising initial findings from its Phase 2a study of SENS-401 to protect … Read more

Biophytis SA, a clinical-stage biotechnology company dedicated to discovering therapeutics that may decelerate the negative effects of aging and improve the welfare of patients afflicted … Read more

Beactica Therapeutics AB, the Swedish precision oncology company, is thrilled to announce the addition of Jarl Ulf Jungnelius M.D. to its Board of Directors. This … Read more

On June 9, the National Innovation Center for Advanced Medical Devices, in partnership with China AGP and Digital Therapeutics R&D Center, and SiBionics held a … Read more

Medivir AB (Nasdaq Stockholm: MVIR) is excited to announce that their patent application for fostering cancer treatment, covering both its substance claims and its usage … Read more

Allgenesis Biotherapeutics Inc., a clinical-stage pharmaceutical company dedicated to developing advanced ophthalmic drugs, recently released exciting topline data from its Phase 1b clinical trial for … Read more

Telix Pharmaceuticals Limited (ASX: TLX, Telix) is pleased to announce that the first patient has been dosed in the groundbreaking clinical trial of TLX250-CDx (89Zr-DFO-girentuximab), … Read more

Azitra, Inc. (NYSE American: AZTR) has announced the launch of its initial public offering of 1,500,000 shares of common stock at a public offering price … Read more

Ferring Pharmaceuticals has successfully increased their second Swiss Franc Bond offering by a remarkable CHF 80 million. This 8-year senior unsecured bond transaction has a … Read more

Viva Biotech Holdings Group (1873.HK) is proud to announce that its CRO business unit Viva Shanghai successfully raised nearly US$ 150 million through equity transfers … Read more

Singleron proudly stands behind their promise as a dependable partner for scientists and clinicians, extending their current portfolio of one-stop-shop solutions for the single cell … Read more

Everest Medicines, a biopharmaceutical company with a focus on making innovative medicines and vaccines accessible to all, is proud to announce that Dr. Mike Berry … Read more

Verastem Oncology, a biopharmaceutical company dedicated to developing innovative treatments for cancer patients, has announced the pricing of an underwritten public offering of 7,181,409 shares … Read more

Reata Pharmaceuticals, Inc., a global biopharmaceutical company striving to develop and commercialize innovative treatments for those living with critical illnesses, is delighted to announce that … Read more

Relief Therapeutics, a biopharmaceutical company with the mission of delivering innovative treatment options to those suffering from select specialty and rare diseases, announced that it … Read more

CancerVAX, Inc., a company focused on transforming cancer treatment through a revolutionary universal cancer vaccine, recently completed an insightful discussion between its CEO Ryan Davies … Read more

Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) is thrilled to announce their selection of Minnetronix Medical to engineer their second-generation infrared light device. This device … Read more

Mablink Bioscience, a groundbreaking biotechnology company committed to enhancing the treatment of cancer using next-generation antibody-drug conjugates (ADCs), is proud to welcome Dr. Pejvack Motlagh, … Read more

GE HealthCare is making history with the first patient scanned in a Phase I clinical trial of [18F]GEH200521, a novel fluorine-18 PET radiopharmaceutical that is … Read more

Genome Corporation, a leader in genomic diagnostics, has made an exciting discovery regarding the connection between gut microbiome and hypertension! A study recently published in … Read more

Astellas Pharma Inc. and Cullgen Inc. are joining forces to make groundbreaking strides in the world of protein degraders. Naoki Okamura, president and CEO of … Read more

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading provider of crucial components to the rapidly growing CGT and biopharma markets, proudly announced that all of its … Read more

Daré Bioscience, Inc. (NASDAQ: DARE) is pleased to announce that Sabrina Martucci Johnson, President and CEO of the pioneering women’s health leader, will be an … Read more

Coya Therapeutics, Inc. (NASDAQ: COYA) has welcomed Dr. Michelle Frazier, Ph.D. to its management team as Senior Vice President of Regulatory Affairs. With her extensive … Read more

MediWound Ltd. (Nasdaq: MDWD), a biopharmaceutical company committed to developing innovative enzymatic therapeutics for healing tissue damage, is thrilled to participate in Maxim Group LLC’s … Read more

Today, DermTech, Inc. (NASDAQ: DMTK), a leader in precision dermatology, announced exciting news for its Melanoma Test (DMT). After evaluating their Pigmented Lesion Assay (PLA) … Read more

Alentis Therapeutics, a clinical-stage biotechnology company pioneering the development of treatments for CLDN1+ tumors and organ fibrosis, is thrilled to announce that the FDA has … Read more

Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with a commitment to improving the lives of those touched by kidney disease, is thrilled to announce … Read more

Covalon Technologies Ltd., a leading medical technologies company, announced that its IV Clear® line of dual antimicrobial silicone dressings has been highly recommended by physicians … Read more

On Tuesday, June 20, 2023, Medigene AG, an immuno-oncology platform company devoted to the development of T cell immunotherapies to combat solid tumors, is hosting … Read more

DEM BioPharma, Inc., an innovative immune-oncology company striving to provide cancer patients with cutting-edge therapies, is proud to announce the addition of Wendy Young, Ph.D., … Read more

Bicycle Therapeutics plc (NASDAQ:BCYC) is pioneering the way forward in a new and differentiated class of therapeutics based on its bicycle peptide technology. On June … Read more

Disc Medicine, Inc. (NASDAQ: IRON) is thrilled to announce the exciting news of its outlook for the future as it dives into the world of … Read more

RadNet, Inc. (NASDAQ: RDNT), a leading provider of cost-effective, fixed-site outpatient diagnostic imaging services, is making a big push by offering 7,575,000 shares of its … Read more

CancerVAX, Inc. has made a groundbreaking breakthrough in the fight against cancer — a universal cancer vaccine! The company has launched a Reg A+ fundraising … Read more

Personalis, Inc. (Nasdaq: PSNL) is thrilled to welcome Kenneth J. Widder, M.D., to its Board of Directors. With over four decades of experience in the … Read more

Gencurix, a leading cancer molecular diagnostics company, has just been granted approval by the Korean Ministry of Food and Drug Safety for the Droplex EGFR … Read more

Trestle Biotherapeutics is celebrating a major milestone today as they have been selected as one of eight winners of the KidneyX Artificial Kidney Prize program, … Read more

ITM Isotope Technologies Munich SE unveiled their new state-of-the-art therapeutic radionuclide production facility in Neufahrn near Munich, Germany. At the ribbon cutting ceremony attended by … Read more

Genzen is thrilled to announce the appointment of two highly accomplished medical professionals, Susan D’Costa, Ph.D., as Chief Technology Officer and Nicole O’Brien, Ph.D., as … Read more

BioInvent International (STO:BINV) is proud to announce that the abstract for the ongoing clinical trial of their BI-1206 in combination with rituximab has been accepted … Read more

Today, Spago Nanomedical AB (publ) is pleased to announce the formation of its Scientific Advisory Board (SAB), a highly esteemed group of oncology and nuclear … Read more

Valo Therapeutics Oy (ValoTx) is thrilled to collaborate with global contract research organization Texcell to investigate immune responses to its revolutionary PeptiCRAd-1 cancer therapy in … Read more

Novaliq GmbH and Japan-based research powerhouse, Senju Pharmaceutical Co., Ltd. are thrilled to announce a new licensing agreement regarding NOV03 (perfluorohexyloctane ophthalmic solution), a precedent-setting … Read more

Augmenting the Japanese ophthalmology industry with a groundbreaking commitment to innovation, two frontrunners in the field, Senju Pharmaceutical and Novaliq GmbH, are delighted to announce … Read more

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, announced today that their pivotal Phase 3 data for their single-shot chikungunya vaccine candidate, … Read more

IRLAB Therapeutics, a Gothenburg, Sweden-based company dedicated to discovering and developing novel treatments for Parkinson’s disease, has announced its upcoming participation in IBAGS XIV, the … Read more

Illumina Inc. (NASDAQ: ILMN), the world’s leading supplier of DNA sequencing and array-based technologies, has accepted the resignation of Francis deSouza as Chief Executive Officer … Read more

Beacon Therapeutics Holdings Limited is launching today with a renewed purpose: Restoring and improving vision for patients with retinal diseases. To make this a reality, … Read more

Oxurion NV, a biopharmaceutical company committed to developing the next-generation of ophthalmic therapies, announced today that it has randomized the last patient in its groundbreaking … Read more

Today, Indivior PLC (LSE: INDV), a global pharmaceutical company working to improve the lives of those suffering from substance use disorders and serious mental illnesses, … Read more

Alvotech and Teva Pharmaceuticals are excited to announce that they have reached a major settlement and license agreement with Johnson & Johnson. The agreement grants … Read more

Futura Medical plc (AIM: FUM), an innovative pharmaceutical company developing products based on its own transdermal DermaSys® drug delivery technology, is proud to announce that … Read more

Sanyou Biopharmaceuticals Co., Ltd. is thrilled to introduce their revolutionary “Sanyou Super Trillion Common Light Chain Antibody Discovery Platform”, which promises to revolutionize the field … Read more

Innovent Biologics, Inc. (HKEX: 01801) proudly announced that its Phase 1 clinical data for the world’s first anti-CD47/PD-L1 bispecific antibody IBI322 treatment of anti-PD-(L)1-resistant classic … Read more

Eccogene Inc., a clinical-stage biotechnology company forging the way in innovative therapeutic solutions for metabolic diseases, today unveiled an astounding CNY 180 million (about $25 … Read more

At the European Hematology Association (EHA) 2023 Hybrid Congress, InnoCare (HKEX: 09969; SSE: 688428) showcased their impressive pipelines and the data associated with them, to … Read more

MTA, a renowned leader in medical gas services, testing, and equipment, is delighted to announce the acquisition of Premier Medical, Inc. This exciting development ties … Read more

Femasys Inc. (NASDAQ: FEMY) has gained major recognition in the biomedical world for developing helpful products and product candidates that meet the needs of women. … Read more

Indica Labs is transforming digital pathology with the launch of their HALO® software-as-a-service offering. Leveraging the power of Amazon Web Services, the service provides organizations … Read more

Avanos Medical, Inc. (NYSE: AVNS) is pleased to announce that it has reached a definitive agreement to sell its Respiratory Health (RH) business to SunMed … Read more

Hyperfine, Inc. (Nasdaq: HYPR) is thrilled to take part in the momentous collaboration between the International Society for Magnetic Resonance in Medicine (ISMRM) and the … Read more

Iktos, the leader in Artificial Intelligence for new drug design, and Curreio, Inc., a Japanese company specialising in structual analys of biomolecules, have teamed up … Read more

Labcorp, a renowned leader in the life sciences industry, today announced an offering of senior secured notes due 2030 from Fortrea Holdings Inc., its wholly … Read more

On June 8th, 2023, history was made as China was the first nation to approve a COVID-19 vaccine for emergency use authorization (EUA). Developed by … Read more

Elevation Oncology, Inc. (Nasdaq: ELEV) announced the launch of an underwritten public offering, wherein the company is offering 17,810,000 shares of its common stock and, … Read more

Astellas Pharma Inc. (TSE:4503, President and CEO: Naoki Okamura), is bringing a novel and first-of-its-kind therapy to Japan! On June 9, 2023, they submitted a … Read more

GE HealthCare Technologies Inc. (Nasdaq: GEHC) is offering 25 million of its shares of common stock at a public offering price of $78.00 per share. … Read more

BioArctic AB has announced that its partner Eisai has submitted a marketing authorization application for lecanemab (LEQEMBI™), an anti-amyloid beta protofibril antibody, as a potential … Read more

The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for SAR’579 / IPH6101 – an innovative treatment for hematological malignancies developed jointly … Read more

Basilea Pharmaceutica Ltd, a biopharmaceutical company specializing in treating serious bacterial and fungal infections, is pleased to announce that milestone payments of USD 26.25 million … Read more

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) is pleased to announce the pricing of $500 million of 1.75% Convertible Senior Notes due 2028 in a private placement, … Read more

Pixium Vision SA, a groundbreaking bioelectronics company pioneering revolutionary bionic vision systems to empower those living with sight loss, has proudly secured an impressive € … Read more

From supporting healthy fetus development to having an exact lifespan, the placenta plays a critical role in pregnancy. Now, scientists at the Stowers Institute for … Read more

Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) appointed Bill Little as Executive Vice President of Corporate Development and Strategy and Andrew Taylor to the role of … Read more

Baudax Bio, Inc. (Nasdaq:BXRX), a pioneering pharma company dedicated to creating innovative medications for acute care, just revealed promising new outcomes from a Phase 2 … Read more

DermTech, Inc. (NASDAQ: DMTK), a leader in precision dermatology, has just taken a big step to further enable access to its innovative Melanoma Test (DMT). … Read more

InfiRay®, a premier brand in the thermal imaging industry, showcased its cutting-edge technologies and unique products at WIN EURASIA 2023, held at Istanbul Expo Center, … Read more

Today, XNK Therapeutics is proud to welcome Hugo Petit as their new Chief Financial Officer. His track record of success and depth of knowledge make … Read more

NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS), a clinical-stage biopharmaceutical company, is offering 13,857,415 ordinary shares of their company to its existing shareholders at a public … Read more

Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company dedicated to developing cutting-edge products for acute care and related settings, has sadly adjourned its Annual Meeting of … Read more

AAVantgarde Bio, an Italian biotechnology company with two groundbreaking Adeno-Associated Viral vector platforms for large gene delivery, is thrilled to announce the successful closing of … Read more

ProtoKinetix, Incorporated, a clinical-stage biomedical company with a mission to develop a cure for Type-1 Diabetes, is delighted to announce the submission of a groundbreaking … Read more

Icometrix, the world leader in imaging artificial intelligence (AI) solutions for people with neurological conditions, has been recognized and awarded a generous grant from The … Read more

Today, Dr. Armen Khachatryan from the Disc Replacement Center successfully completed the first series of lumbar total joint replacement surgeries using the revolutionary MOTUS technique … Read more

SYBLEU Inc., a revolutionary biotech company focused on providing cutting-edge therapies and medical devices for human and animal health, as well as clinical diagnostics, is … Read more

Today, Thryv Therapeutics Inc. made a remarkable foray into the world of financing with a USD $5,000,000 convertible note investment by Investissement Québec (IQ). Now, … Read more

AccuStem Sciences, Inc. (OTCQB: ACUT) has established a new joint clinical collaboration with University Hospitals that promises to improve cancer patients’ outcomes. This partnership combines … Read more

Conformal Medical, Inc., a trailblazing medical device company, has achieved a major milestone with the successful completion of its latest Series D funding round, having … Read more

Vaxxas Inc., a clinical-stage biotechnology company determined to revolutionize vaccine development and delivery, is thrilled to announce the successful outcome of the first interim results … Read more

Lucid Diagnostics, a commercial-stage cancer prevention diagnostics company and majority-owned subsidiary of PAVmed Inc., is excited to announce the launch of its first EsoGuard® #CheckYourFoodTube … Read more

Charles River Laboratories International is excited to announce that it will be participating in the William Blair 43rd Annual Growth Stock Conference on Tuesday, June … Read more

Breast Cancer Canada is helping to save lives by pledging an incredible $3-million in funding to the world-renowned Princess Margaret Cancer Centre, University Health Network, … Read more

At the upcoming American Transplant Congress (ATC) 2023 in San Diego, CA, biotechnology company eGenesis will reveal groundbreaking data on xenotransplantation – the transplantation of … Read more

Vor Bio, a clinical-stage cell and genome engineering company listed on Nasdaq (VOR), is joining the Goldman Sachs 44th Annual Global Healthcare Conference with a … Read more

T2 Biosystems, Inc., a pioneer in the field of rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that they have submitted an … Read more

Variant Bio is thrilled to welcome two world-renowned biopharma innovators to its team: David Moller, MD as Chief Scientific Officer and Steve Bryant, PhD as … Read more

Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, is reporting encouraging results for its telomerase inhibitor, imetelstat, in low-risk patients with myelodysplastic syndrome (MDS). … Read more

Promontory Therapeutics Inc., a clinical stage pharmaceutical company advancing innovative small molecule immunotherapies in oncology, is proud to report preliminary data from a Phase 2 … Read more

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) is revolutionizing the treatment of prostate disease with its completely incision-free, MRI-monitored Transurethral Ultrasound Ablation (TULSA) treatment system, the TULSA-PRO®. … Read more

Today, Theratechnologies Inc., a biopharmaceutical company focused on development and commercialization of innovative therapies, is pleased to announce that the United States Food and Drug … Read more

Omniscient, the pioneering AI company making breakthroughs in understanding the human brain, has just received FDA clearance for their new software release ‘Quicktome FC (Functional … Read more

BostonGene has unveiled the latest in healthcare innovation with the launch of its Liquid Biopsy, Immunoprofiling and Spatial Proteomics solutions. These comprehensive services integrate AI-based … Read more

AESOP Technology and AstraZeneca Taiwan have joined forces to deliver Medigator – a revolutionary AI software that enables a safe and effective experience with immunotherapy! … Read more

PharmaEssentia Corporation, a leading biopharmaceutical company in Taiwan, is proud to announce an exclusive license agreement with Pint-Pharma GmbH to register and promote BESREMi® (ropeginterferon … Read more

Providence Therapeutics Holdings Inc., a biopharmaceutical company at the forefront of mRNA drug discovery, has announced an exciting partnership with University Health Network, Canada’s number … Read more

At the 2023 ASMS conference in Houston, Texas, Expert Intelligence (EI) unveiled its revolutionary AI Application Builder for Mass Spectrometry analysis. This amazing new tool … Read more

Today, Invivoscribe and Complete Genomics announced a comprehensive partnership to transform oncology and cancer research around the world. The two companies have combined forces to … Read more

AOP Health has made an important advancement reinforcing its clinical development program for ropeginterferon alpha-2b (BESREMi®) in polycythaemia vera (PV), a rare blood cancer. This … Read more

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company dedicated to unlocking the potential of oral, small molecule protease inhibitors, announced its multiple abstracts … Read more

BioNTech SE and OncoC4, Inc. are thrilled to announce preliminary data from a Phase 1/2 trial showing promising clinical anti-tumor activity for their anti-CTLA-4 antibody … Read more

Hemogenyx Pharmaceuticals plc (LSE:HEMO) has received a clinical hold notice from the U.S. Food and Drug Administration in regard to their Investigational New Drug application … Read more

Today, Senseonics Holdings, Inc. – a medical technology company that develops and manufactures long-term and implantable continuous glucose monitoring (CGM) systems – announced some exciting … Read more

Affini-T Therapeutics, Inc., a precision immunotherapy company transforming the field of cancer treatment, is proud to welcome Thaminda Ramanayake as Chief Business Officer. With over … Read more

Today Foundation Medicine, Inc., has unveiled the launch of its cutting-edge ctDNA monitoring assay, FoundationOne®Monitor – available for research use in retrospective studies. FoundationOne Monitor … Read more

Illumina, Inc. (NASDAQ: ILMN), a pioneer in cutting-edge DNA sequencing and array-based technologies, today unveiled plans to maximize shareholder value over the long term through … Read more

MEI Pharma, Inc. (NASDAQ: MEIP) has announced that Daniel P. Gold, Ph.D. will conclude his tenure as the president and chief executive officer of MEI … Read more

Myriad Genetics, Inc. (NASDAQ: MYGN) strengthens its commitment to the future of precision medicine with the appointment of renowned oncologist Adam Brufsky, MD, PhD, FACP … Read more

Tenax Therapeutics, formerly known as Oxygen Biotherapeutics, Inc., has been granted a Notice of Allowance by the USPTO for its patent application that covers the … Read more

Fate Therapeutics, Inc., the clinically-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer … Read more

Sensei Biotherapeutics, Inc. (Nasdaq: SNSE) is excited to announce that John Celebi, President & Chief Executive Officer, will be presenting at the renowned Jefferies Global … Read more

Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) announced that its management team will be participating in the Jefferies Healthcare Conference, and is excited to share their vision for … Read more

Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) is gearing up to give a live Fireside Chat at the Jefferies Healthcare Conference on June 8th at 10:30am ET. … Read more

Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), an innovative clinical-stage oncology company and leader in pioneering novel-format antibody drug conjugates (ADCs), announced that … Read more

Cocrystal Pharma, Inc. (Nasdaq: COCP) is thrilled to announce that they have been granted approval from the Australian Human Research Ethics Committee (HREC) to initiate … Read more

Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT) is thrilled to announce that it will be participating in the Jefferies Healthcare Conference in New York City on June … Read more

Today, Armis Biopharma, Inc. announced a major breakthrough – the VeriCyn® Wound Wash medical device, now cleared by the U.S. Food and Drug Administration (FDA). … Read more

ValnevaSE, a specialty vaccine company, is pleased to invite shareholders and other interested parties to attend its Combined General Meeting on June 21, 2023 at … Read more

Cellular Origins, a TTP Company pioneering a new era of scalable, cost-effective and space-efficient cell and gene therapies (CGTs) manufacturing, is proud to present the … Read more

Alvotech, a leading global biotech company dedicated to the development and production of pioneering biosimilar medicines, is excited to announce their participation at the Jefferies … Read more

ValnevaSE, a specialty vaccine company, will have senior members of its team in the U.S. and France to take part in some of the highest-profile … Read more

Ostentus Therapeutics, Inc. has taken a bold step forward in the fight against cancer by entering into a second Sponsored Research Agreement with City of … Read more

Yuhan Corporation (CEO, Wook-Je Cho), on May 30th, unveiled an exciting in-license agreement with J INTS BIO (CEO,Anna Jo). Worth $325 million in total, the … Read more

IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A) is excited to announce that its Phase IIb study of pirepemat (IRL752) is now recruiting patients at 38 … Read more

Anocca AB is thrilled to announce that it has successfully raised an incredible SEK 400 million through an equity financing round led by AMF and … Read more

Sanofi’s innovative second-generation investigational anti-CD40L antibody, Frexalimab, has astounded experts in the field by significantly reducing disease activity in patients with relapsing multiple sclerosis (MS). … Read more

Today, Ascentage Pharma, a global biopharmaceutical company focused on developing therapies for cancer, CHB, and age-related diseases, received some fantastic news. The Center for Drug … Read more

On June 20th, 2023, Relief Therapeutics proudly invites its shareholders to its Annual General Meeting held at the gorgeous avenue de Sécheron 15 in Geneva, … Read more

Join Bridge Biotherapeutics Inc. (KQ288330) at the 2023 BIO International Convention in Boston, Massachusetts on Tuesday, June 6, as Director of Business Development Pavel Printsev … Read more

Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”) announced that it has teamed up with Charles River to conduct a GLP toxicology study … Read more

Titan Medical Inc. (TSX: TMD; OTC: TMDIF) today provided a corporate update and also offered an update on their current default status in accordance with … Read more

Roche Canada is thrilled to announce that negotiations with the pan-Canadian Pharmaceutical Alliance (pCPA) have come to a successful conclusion. VABYSMO® (faricimab injection) is now … Read more

AbCellera is taking the stage! Executives from the Company will be presenting at the highly anticipated Goldman Sachs 44th Annual Global Healthcare Conference on Tuesday, … Read more

At its Annual Meeting of Shareholders held on May 29, 2023, Extendicare Inc. (TSX: EXE) – or the Company – saw all the nominees listed … Read more

Today, iNtRON Biotechnology is thrilled to announce the discovery of Prophage and (non-) ORF-Jamphage from the microbiome commonly found in long-term Pancreatic cancer survivors. This … Read more

AstriVax is delighted to have received a €2.5 million grant from Flanders Innovation & Entrepreneurship (VLAIO) in support of their revolutionary technology. This exciting development … Read more

Novotech, the premier Asia Pacific centred biotech CRO is proud to sponsor the BIO 2023 APAC Summit, and its session on Forging New Biotech Ties … Read more

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the following investor conferences. Experience an amazing … Read more

Schrödinger, a revolutionary innovator in physics-based computational technology, will be featured in a fireside chat at the Jefferies Healthcare Conference on Wednesday, June 7, 2023. … Read more

Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a leader in the development of innovative therapies to treat seizure disorders, is proud to announce that the European Medicines … Read more

Ferring Pharmaceuticals and its clinical development partner, Seikagaku Corporation, have achieved a major milestone in their clinical trials of SI-6603. After positive topline results in … Read more

Biodynamic Technologies is delighted to announce a pioneering breakthrough in the early detection of pancreatic pre-cancer lesion – as detailed in their newly published case … Read more

At the 2023 ASCO Annual Meeting in Chicago, USA, Abbisko Therapeutics Co., Ltd. is set to reveal the latest findings of their Phase Ib clinical … Read more

At the ISID 2023 Tokyo Satellite Meeting, collaborators from Keio University and Osaka University showcased groundbreaking findings from a murine model of pemphigus. Through the … Read more

Amplia Therapeutics Limited (ASX: ATX) is thrilled to announce the outstanding results of AMP945, its investigational FAK inhibitor, when used in combination with FOLFIRINOX in … Read more

Hummingbird Bioscience is paving the way for groundbreaking, cutting-edge treatments with its upcoming presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting in … Read more

Harbour BioMed, a global biopharmaceutical firm dedicated to the discovery, development, and commercialization of revolutionary antibody treatments, has recently unveiled the outcomes of the phase … Read more

Innate Pharma SA is proud to announce that the latest research concerning its SAR443579 drug’s benefits for relapsed or refractory acute myeloid leukemia, B-cell acute … Read more

Gilead Sciences, Inc. (Nasdaq: GILD) announced exciting news today regarding its antiviral treatment Veklury (remdesivir). It has received a positive opinion from the Committee for … Read more

Occlutech Holding AG is an innovative pioneer in the medical device industry, providing minimally invasive structural heart implants to 85 countries around the world. By … Read more

Invitae (NYSE: NVTA), a leading medical genetics company, today announced the upcoming departure of Chief Financial Officer (CFO) Yafei (Roxi) Wen. Ms. Wen will step … Read more

Biophytis SA (NasdaqCM:BPTS)(Euronext Growth Paris:ALBPS), a clinical-stage biotechnology company dedicated to developing therapeutics that combat the degenerative effects of aging, has submitted an application for … Read more

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company on a mission to uncover and develop targeted therapeutics, today announced a major grant of … Read more

Antengene Corporation Limited (SEHK: 6996.HK), a pioneering global biopharmaceutical company, is thrilled to announce that the newest findings from its Phase I/II TORCH-2 study have … Read more

Castellum, Inc., a leading cybersecurity and electronic warfare services provider serving Federal Government clients, is taking the bold step of committing to a major cost … Read more

In February 2023, responding to Japanese Prime Minister Fumio Kishida’s goal to develop the domestic cultivated food industry, the Japan Association for Cellular Agriculture (JACA) … Read more

Genexine, a Korean biopharmaceutical company dedicated to the production of life-saving treatments, has announced the publication of their groundbreaking phase 2 clinical trial data in … Read more

On June 7-9, 2023, NeuBase Therapeutics, Inc. (Nasdaq: NBSE) will be showcasing their Stealth Editors™ at the Jefferies Healthcare Conference at the Marriott Marquis in … Read more

Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) is taking a major step forward in the fight against Alport syndrome – a rare genetic disease – with the … Read more

Pliant Therapeutics, Inc. (Nasdaq: PLRX) is thrilled to present exciting data from its Phase 2a clinical trials and preclinical studies on bexotegrast (PLN-74809), its novel … Read more

Rani Therapeutics Holdings, Inc., a clinical-stage biotherapeutics company dedicated to revolutionizing the way we take our medication, proudly announces the appointment of Kate McKinley as … Read more

Lisata Therapeutics, Inc. (Nasdaq: LSTA) is continuing their ASCEND trial, aPhase 2b trial investigating their investigational drug, LSTA1, when paired with the standard-of-care gemcitabine/nab-paclitaxel in … Read more

Immutep Limited (ASX:IMM; NASDAQ:IMMP), a clinical-stage biotechnology company developing innovative LAG-3 immunotherapies for cancer and autoimmune diseases, is excited to share new promising clinical data … Read more

Spectral Medical Inc. (TSX: EDT) recently hosted an investigator meeting in Charlotte, North Carolina on May 17 to 18, 2023. This in-person event was attended … Read more

Azenta, Inc. (Nasdaq: AZTA) has been chosen by The Lupus Research Alliance and its clinical research affiliate Lupus Therapeutics to revolutionize lupus research and drug … Read more

Ambrx Biopharma Inc. (NASDAQ: AMAM) is pleased to announce the completion of its registered direct offering with clients managed by Darwin Global Management Ltd., which … Read more

Palisade Bio Inc. (Nasdaq:PALI), a biopharmaceutical company advancing therapies for acute and chronic gastrointestinal complications, recently announced an update to its clinical program for its … Read more

Halberd Corporation (OTC PINK:HALB) has made huge strides towards its groundbreaking nasal spray to combat Traumatic Brain Injury (TBI). After initial preclinical phase testing by … Read more

Talis Biomedical Corporation (Nasdaq: TLIS), a leading diagnostics company committed to delivering accurate disease testing at the point of care, has taken two important steps … Read more

NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS) is making strides in the research and development of cardiometabolic disease treatments with the full data from their ROSE2 … Read more

T2 Biosystems Inc. (NASDAQ:TTOO) has skyrocketed to the forefront of early detection of dangerous sepsis-causing pathogens and antibiotic resistance genes with their newly submitted T2Biothreat™ … Read more

Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT) is pleased to announce that it has signed a definitive agreement to offer for sale a total of 3,256,269 … Read more

Theralink Technologies, Inc. (OTC: THER) and IMAC Holdings, Inc. (Nasdaq: BACK) have joined forces in a groundbreaking stock-for-stock reverse merger transaction, which will create an … Read more

At Avalyn Pharma Inc., safety and tolerability of AP01 (inhaled pirfenidone), an experimental inhaled drug candidate in development for the treatment of pulmonary fibrosis, was … Read more

89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company dedicated to developing and commercializing groundbreaking therapies for the treatment of liver and cardiometabolic diseases, is proud … Read more

Ocean Biomedical (NASDAQ: OCEA) is proud to announce a major breakthrough in cancer immunotherapy! Its Scientific Co-founder, Dr. Jack A. Elias, MD, has recently been … Read more

T2 Biosystems Inc. (NASDAQ:TTOO), a leading innovator in the fight against sepsis, is taking a bold move to maximize value through a strategic alternatives process. … Read more

AnaMar, a clinical-stage biotech revolutionizing the treatment of systemic sclerosis (SSc), has just announced remarkable results from its Phase I trial with AM1476, their first-in-class, … Read more

This year, OMRON Healthcare Co., Ltd. celebrates 50 years of producing the world’s most accurate and consumer-friendly blood pressure monitors. With more than 350 million … Read more

LUND, Sweden– On May 23, 2023, the world witnessed a remarkable breakthrough engineered from the European nation of Sweden. After years of dedicated research, scientists … Read more

Carmot Therapeutics, Inc., a clinical-stage biotechnology company, is thrilled to be participating in the American Diabetes Association Annual Meeting from June 23–26, 2023 in San … Read more

Spago Nanomedical AB (publ) is thrilled to announce the upcoming commencement of its clinical phase I/IIa trial, Tumorad-01, utilizing its leading drug candidate 177Lu-SN201. After … Read more

Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, is excited to announce the pricing of their public offering showcasing 1,896,286 shares of their common … Read more

Guardant Health, Inc. (Nasdaq:GH), a leading precision oncology company, is pleased to announce the successful pricing of a highly anticipated underwritten public offering of 12,500,000 … Read more

Today, Propanc Biopharma, Inc. (OTC Pink: PPCB) announced an exciting development for its stakeholders: the board of directors has approved a reverse stock split of … Read more

BioMimetix, a cutting-edge medtech company developing biomorphic programmable polymers for tissue reconstruction, has just announced the closure of its Series D round, raising an impressive … Read more

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) is pleased to announce that members of its senior management team will be speaking at a series … Read more

Daxor Corporation (Nasdaq: DXR) is proud to announce the pricing of its underwritten public offering of 410,260 shares of common stock at $9.75 per share. … Read more

Panbela Therapeutics Inc. (Nasdaq: PBLA) is thrilled to announce it has taken a bold step forward in treating patients with STK11 mutant non-small cell lung … Read more

Coherus BioSciences, Inc. (Nasdaq: CHRS), is proud to introduce its revolutionary single-dose, prefilled UDENYCA® (pegfilgrastim-cbqv) autoinjector to the United States market. UDENYCA® is an incredibly … Read more

The FDA has accepted the Premarket Approval application for Lumicell™ Direct Visualization System, allowing for a revolutionary imaging technique that provides clear visualization of cells … Read more

Yaral Pharma, the US generics subsidiary of IBSA, is proud to partner with Eversana®, a leader in global life sciences services to help broaden its … Read more

Boehringer Ingelheim Pharmaceuticals, Inc. is pleased to announce that the U.S. Food and Drug Administration has granted approval for the launch of the all-new Cyltezo … Read more

On Monday, May 22, 2023, NanoString Technologies, Inc. (NASDAQ:NSTG) will be hosting an informative conference call at 4:30pm ET to discuss a noteworthy ruling in … Read more

As we mark Gout Awareness Day on May 22, 2023, Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd., a clinical stage biotechnology company, is calling for … Read more

Kelyniam Global (OTC: KLYG), a pioneer in custom cranial implants, has released its financial report for the quarter ending March 31, 2023. The company continues … Read more

Eisai, the partner of BioArctic AB’s (publ), an emerging life sciences company listed on NASDAQ Stockholm, has just taken a major step towards realizing their … Read more

Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO) has taken action to further its vision of developing groundbreaking cell and gene therapies to combat … Read more

The three-judge panel of Louisiana’s 5th Circuit Court of Appeal grilled the Food and Drug Administration (FDA) during Wednesday’s oral arguments, pressing for details on … Read more

AstraZeneca signed a non-exclusive deal with Massachusetts biotech Revvity on Thursday to gain access to their exclusive gene-editing technology, which will be used to develop … Read more

The U.S. Supreme Court has delivered a long-anticipated victory to pharmaceutical giants Sanofi and Regeneron, ruling unanimously in their favor in a decade-long battle with … Read more

A potential breakthrough in pediatric health care is on the horizon, as the FDA reviewed documents from Pfizer that suggest their experimental Abrysvo vaccine against … Read more

Agilent Technologies Inc. (NYSE: A) today stated its intention to challenge the ruling of the U.S. Patent and Trademarks Office’s (USPTO) Patent Trial and Appeal … Read more

Sobi has announced exciting news – the European Medicines Agency (EMA) has officially accepted and validated their application for the revolutionary treatment efanesoctocog alfa for … Read more

CorFlow Therapeutics AG, a clinical-stage company pioneering combined diagnosis and therapy systems for coronary microvascular obstructions (MVO), presented interim positive results from its MOCA I … Read more

Humanetics Biomed is an innovative Contract Development Manufacturing Organisation (CDMO) that utilises the latest biomedical technologies and precise lasered components and subcomponents from Humanetics to … Read more

AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pioneering pharmaceutical company striving to innovate a robust portfolio of small molecule candidate drugs for the treatment of … Read more

At the Protein Engineering Summit (PEGS) and at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting in Los Angeles, Orna Therapeutics presented … Read more

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK) has launched a new clinical trial in the U.S. to test the effectiveness of its innovative CAR T-cell … Read more

SiteOne Therapeutics, Inc. has just received a $15 million grant from the National Institute on Drug Abuse as part of the NIH HEAL Initiative, a … Read more

Xtant Medical Holdings, Inc. (NYSE American: XTNT) is delighted to announce the appointment of Lori Mitchell-Keller to its Board of Directors, effective May 16, 2023. … Read more

IQVIA Holdings Inc. (NYSE:IQV), a wholly-owned subsidiary of IQVIA Inc., has announced plans to raise $1 billion dollars through an offering of senior secured notes … Read more

Myeloid Therapeutics, Inc., a clinical stage mRNA-immunotherapy company, announced today the successful completion of an impressive $73 million financing round. The investment was led by … Read more

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its oral health care division, OraPharma, Inc., have recently published the results of a new study which showed that … Read more

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) has published groundbreaking findings from the CAMEO study in the journal Hepatology Communications, providing new insights into the safety, tolerability, … Read more

HeartBeam, Inc. (NASDAQ: BEAT), a groundbreaking cardiac technology company, has taken an incredible step forward in the medical industry today with the submission of a … Read more

Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company dedicated to developing innovative biotherapeutics, has announced the departure of Neil Klompas, President and Chief Operating Officer. … Read more

Thermo Fisher Scientific Inc. (NYSE: TMO) today released its 2020 Corporate Social Responsibility (CSR) report to showcase its ongoing commitment to society and stakeholders. The … Read more

Biocept, Inc. (Nasdaq: BIOC) is proud to announce that its 1-for-30 reverse stock split became effective at 4:05 p.m. Eastern Time on May 16, 2023 … Read more

Lumen Bioscience, a clinical-stage biotechnology company developing biologic drugs for highly prevalent diseases, is excited to announce that the U.S. Food and Drug Administration (FDA) … Read more

Verismo Therapeutics, a clinical-stage CAR T company, Penn spinout, and leader in the development of the innovative KIR-CAR platform technology, is thrilled to welcome Sara … Read more

Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) is proud to announce the appointment of Brian Cogley, MBA, as the new Chief Financial Officer (CFO). With 15 … Read more

ImmunoBrain Checkpoint Inc. (IBC), a pioneering biopharmaceutical company creating cutting-edge disease-modifying immune therapies to fight neurodegenerative diseases, has just administered its first two dosages of … Read more

STRM.BIO, a pre-clinical biotechnology company pioneering gene therapies utilizing extracellular vesicles (EVs) to treat rare blood diseases, today announced the appointment of Dawn Bell, PharmD … Read more

Evox Therapeutics Ltd, a pioneering exosome therapeutics company, is proud to announce that the US Patent and Trademark Office has granted the Company another patent … Read more

IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company focused on gamma-delta T cell therapies, recently unveiled impressive preclinical data at the American Society of Cell … Read more

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) announced today that the U.S. Food and Drug Administration (FDA) has approved an amendment to the Phase 1/2 study of … Read more

Sangamo Therapeutics, Inc. (Nasdaq: SGMO) is pleased to announce the appointment of Lisa Rojkjaer, M.D., as the company’s new Chief Medical Officer. An esteemed leader … Read more

Immutep (formerly known as Prima Biomed) Limited (ASX: IMM; NASDAQ: IMMP) is thrilled to announce it has received a positive response from the US Food … Read more

YS Biopharma, a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer, … Read more

Ray Therapeutics, a pioneering optogenetics company, has announced an oversubscribed $100M Series A financing round backed by some of the world’s most influential investors. Novo … Read more

Regulus Therapeutics, Inc. (Nasdaq: RGLS) is thrilled to announce that it is progressing to the second cohort of patients in the Phase 1b MAD study … Read more

Milestone Scientific, Inc. (NYSE:MLSS) is thrilled to announce that its revolutionary CompuFlo® Epidural disposables have been met with great success in Torrance, California. After a … Read more

Chinook Therapeutics, Inc. (Nasdaq: KDNY) and Ionis Pharmaceuticals, Inc. have joined forces to develop a cutting-edge antisense oligonucleotide (ASO) therapy to treat a rare, severe … Read more

Biocoat, Inc., a leading manufacturer of hydrophilic biomaterial coatings and coating equipment for medical devices, is pleased to announce the appointment of Gregory (Greg) Santorno … Read more

X4 Pharmaceuticals, Inc. (Nasdaq: XFOR) has just announced a major investment victory for its future! The leading discovery and development company for novel small molecule … Read more

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP), a clinical stage biopharmaceutical company developing a groundbreaking new class of antibiotics for difficult-to-treat bacterial infections, has announced that it … Read more

Potrero Medical, Inc., innovator of the Accuryn Monitoring System, is proud to announce that Maclean Health has been appointed as its Exclusive Distributor of Record … Read more

Nusano, Inc. and PharmaLogic have joined forces to revolutionize the production of cancer-fighting radioisotopes, creating innovative radiopharmaceuticals for diagnostic and therapeutic purposes. As a world-class … Read more

Gracell Biotechnologies Inc. (NASDAQ: GRCL), a global biopharmaceutical company dedicated to revolutionizing the treatment of cancer and autoimmune diseases, is delighted to announce the launch … Read more

Rona Therapeutics, Inc and Keymed Biosciences are teaming up to launch a groundbreaking collaboration to create the first-ever siRNA therapeutics for Glomerulonephritis, a severe kidney … Read more

Avantor Performance Materials, Inc. (NYSE: AVTR) announced today that Executive Vice President and Chief Financial Officer Thomas A. Szlosek will be leaving the Company effective … Read more

Dante Genomics, a pioneering force in genomics and precision medicine, is introducing a groundbreaking feature to its AVANTI Software—free of charge! This platform agnostic software … Read more

ImmPACT Bio, a clinical-stage company developing groundbreaking CAR T-cell therapies for cancer and autoimmune diseases, today announced that the U.S. Food and Drug Administration (FDA) … Read more

Ikena Oncology, Inc. (Nasdaq: IKNA) is forging a new path in patient-directed cancer treatment with the pricing of an underwritten offering of 6,110,000 shares of … Read more

Therini Bio, Inc., a biotech company dedicated to researching and developing fibrin-targeted therapies, is ushering in a new era of medical treatments with the start … Read more

Today, Juno Pharmaceuticals Canada (“Juno”) has taken a major step forward in the commercialization of specialty pharmaceuticals, with the acquisition of Omega Laboratories (“Omega”) – … Read more

The FDA’s Nonprescription Drugs Advisory Committee and Obstetrics, Reproductive and Urologic Drugs Advisory Committee have given their unanimous go-ahead for Perrigo’s birth control drug, Opill … Read more

Mirion Technologies, Inc. (NYSE: MIR), a global leader in radiation detection, measurement, analysis, and monitoring solutions for the medical, nuclear, defense, and research sectors, today … Read more

Cellectis, a clinical-stage biotechnology company using its groundbreaking gene-editing platform to develop revolutionary cell and gene therapies, recently revealed the impressive results of its TALEN® … Read more

The Company is pleased to announce the appointment of Professor Solange Peters as an Independent Non-executive Director, member of the Technical Committee and member of … Read more

Walgreens Boots Alliance, Inc. (Nasdaq: WBA) has announced the sale of shares of AmerisourceBergen Corporation (NYSE: ABC) common stock through a series of variable prepaid … Read more

The Beijing Puhui Health Insurance Program has added an imported version of Nefecon (budesonide) delayed release capsule to its 2023 New Reimbursement Drug List of … Read more

At ESMO Breast Cancer Congress 2023 in Berlin, Veracyte, Inc. (Nasdaq: VCYT) presented new findings from EMIT, a multi-year, population-based study in Norway. The data … Read more

Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company, has announced the impressive results from their Phase 1b trial of gedatolisib, a pan-PI3K/mTOR inhibitor, in combination with … Read more

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) is pleased to announce its participation in the upcoming Lytham Partners Spring 2023 Investor Conference. The virtual event will … Read more

IntraOp Medical Corporation has made history with the successful launch of the world’s first Phase II Electron FLASH Trial. This trial is a groundbreaking advancement … Read more

ExtendBio, the clinical stage biopharmaceutical company developing advanced therapeutic peptides, today announced positive results from its first-in-human trial of EXT608. The interim analysis indicated that … Read more

Bicycle Therapeutics Limited (NASDAQ: BCYC) and Orano Med have announced remarkable pre-clinical results for Pb-BCY20603, their innovative Bicycle® radio-conjugate (BRC™). This BRC™ binds to the … Read more

CovationBio™—a renowned biomaterials firm known for its Sorona®, Susterra®, and Zemea® propanediol offerings—has unveiled its inaugural sustainability report less than one year after becoming an … Read more

Lumen Bioscience, a clinical-stage biotechnology company, has been awarded an $8.8 million project by the United States Department of Defense (DOD) to develop and test … Read more

SERB Pharmaceuticals and SFJ Pharmaceuticals proudly announce a groundbreaking development in the pharmaceutical realm: SERB has acquired exclusive US rights to the ticagrelor reversal agent … Read more

Cytokinetics, Inc. (Nasdaq: CYTK) is excited to announce that the first participants have been successfully dosed in a Phase 1 clinical study of CK-4021586 (CK-586)! … Read more

Tesis Biosciences has revolutionized the way we identify genetic mutations associated with Covid-19 risk. Their groundbreaking new test utilizes targeted genetic sequencing to pinpoint the … Read more

Angelini Pharma and JCR Pharmaceuticals Co., Ltd. (TSE 4552) have joined forces to develop and commercialize cutting-edge biologic therapies that use J-Brain Cargo®, a revolutionary … Read more

Cellular Origins, a TTP Company specializing in cost-effective, efficient, and scalable cell and gene therapy (CGT) manufacture, is teaming up with ScaleReady—a joint venture of … Read more

Today, Soligenix Inc. (Nasdaq: SNGX) announced that the U.S. Food and Drug Administration (FDA) has granted a Type A meeting to discuss the design of … Read more

Transgene (Euronext Paris: TNG), a pioneering biotech firm leading the way in cancer treatments, has announced that their first patient has been dosed in the … Read more

Cerevel Therapeutics, a leader in neuroscience research, is pleased to announce the appointment of Susan Altschuller, Ph.D. as its new Chief Financial Officer. Dr. Altschuller … Read more

SwiftBio Therapeutics, a gene therapy research and development company, has conducted a healthcare resource use study on the devastating effects of AMN (adrenomyeloneuropathy). The study … Read more

Addex Therapeutics, a leader in allosteric modulation-based drug discovery and development, has announced that an Independent Interim Review Committee (IRC) has recommended the continuation of … Read more

HUTCHMED (China) Limited (“HUTCHMED” or the “Company”) (Nasdaq/AIM:​HCM, HKEX:​13) is delighted to announce that Professor Solange Peters has been appointed as an Independent Non-executive Director, … Read more

Alvotech, a global biotech company dedicated to developing and producing biosimilar medicines for patients worldwide, is proud to announce a new exclusive agreement with Polifarma … Read more

Ribbon Biolabs, a leader in the field of DNA synthesis, is pleased to welcome Jodi Barrientos as its new Chief Business Officer. With over 17 … Read more

CTI BioPharma (Nasdaq: CTIC) has entered into a definitive agreement with Swedish Orphan Biovitrum AB (STO: SOBI) to be acquired in an all-cash transaction worth … Read more

At the 4th Annual Dermatology Drug Development Summit Europe on May 22-24, 2023, in Berlin, Germany, UNION therapeutics A/S (UNION) CEO Dr. Kim D. Kjøller … Read more

FE Inc., a cutting-edge microfluidics company focused on revolutionizing the development and production of advanced cell therapies, is proud to announce the launch of its … Read more

Biophytis SA (NasdaqCM:BPTS)(Euronext Growth Paris:ALBPS) is thrilled to announce its recent filing for a pre-submission meeting with the European Medicine Agency (EMA) to discuss the … Read more

Ochre Bio, a leader in the development of treatments for chronic liver disease, is taking part in upcoming investor and industry conferences to deliver expert … Read more

Novotech, the premier Asia Pacific-based biotech CRO, teamed up with Citeline to conduct a survey among global biotech professionals, seeking to gain insights into their … Read more

On April 22, Neuboron Medical Group (NMG), a leading global Accelerator-based Boron Neutron Capture Therapy (AB-BNCT) total solution provider, and Xiamen Humanity Hospital (XHH) joined … Read more

Engitix Ltd, a biotechnology company pioneering the use of its proprietary human extracellular matrix (ECM) platform for drug discovery across fibrosis and solid tumours, is … Read more

BioNxt Solutions Inc. is thrilled to announce the successful completion of a human pilot study for a top European-based generic drug company. BioNxt proudly developed … Read more

Interius BioTherapeutics, a preclinical stage gene therapy company, has announced a manufacturing partnership with WuXi Advanced Therapies (WuXi ATU) to bring its innovative INT-2104 gene … Read more

BellaSeno GmbH, an ISO 13485-certified medtech company with a cutting-edge approach to additive manufacturing technologies, has just reported highly encouraging interim results from two clinical … Read more

SphingoTec has achieved a major milestone, having been re-certified according to ISO 13485 and receiving its first IVDR certificate for its IVD product sphingotest® penKid®. … Read more